Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.
about
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyIn Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.Emerging corticosteroid agonists for the treatment of asthma.The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma.
P2860
Q28074802-86E81D6B-0241-417D-A573-8D97B184F581Q36388505-94DE79D9-BA0C-4901-85D8-30709E996FF9Q36388517-FF47F6A3-A88C-488E-BE98-BB53F2B44104Q37436410-4E7B28EE-03E6-4928-8E5A-EC5AFADF83B4Q38537176-0272D5EB-B594-4D1C-8380-9FA46983AA8AQ38669520-7EF13AD3-4446-40D5-BA95-CF6B59A9BBDBQ38707759-6CBAFBD5-34DC-440D-A1C6-FDEB264474B6Q38947467-201C893E-6888-42F3-824F-CA9A9086FEDA
P2860
Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@ast
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@en
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@nl
type
label
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@ast
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@en
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@nl
prefLabel
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@ast
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@en
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@nl
P2093
P2860
P50
P1433
P1476
Efficacy and safety of once-da ...... a: a 12-week randomized trial.
@en
P2093
Eric D Bateman
Hilary Medley
Loretta Jacques
P2860
P2888
P356
10.1186/S12931-014-0088-Z
P577
2014-08-11T00:00:00Z
P5875
P6179
1019843773